Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough

被引:13
|
作者
Fornaro, Lorenzo [1 ]
Fanotto, Valentina [2 ]
Musettini, Gianna [1 ]
Uccello, Mario [3 ]
Rimassa, Lorenza [4 ]
Vivaldi, Caterina [1 ]
Fontanella, Caterina [2 ]
Leone, Francesco [5 ]
Giampieri, Riccardo [6 ]
Rosati, Gerardo [7 ]
Lencioni, Monica [1 ]
Santini, Daniele [8 ]
Di Donato, Samantha [9 ]
Tomasello, Gianluca [10 ]
Brunetti, Oronzo [11 ]
Pietrantonio, Filippo [12 ]
Bergamo, Francesca [13 ]
Scartozzi, Mario [14 ]
Avallone, Antonio [15 ]
Lutrino, Stefania Eufemia [16 ]
Melisi, Davide [17 ]
Antonuzzo, Lorenzo [18 ]
Pellegrino, Antonio [19 ]
Gerratana, Lorenzo [2 ]
Cordio, Stefano [3 ]
Vasile, Enrico [1 ]
Aprile, Giuseppe [2 ,20 ]
机构
[1] Azienda Osped Univ Pisana, Unit Med Oncol 2, I-56126 Pisa, Italy
[2] Univ & Gen Hosp, Dept Oncol, I-33100 Udine, Italy
[3] Garibaldi Nesima Hosp, Dept Oncol, I-95122 Catania, Italy
[4] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Med Oncol & Hematol Unit, I-20089 Rozzano, MI, Italy
[5] IRCCS, Inst Canc Res & Treatment, I-10060 Candiolo, TO, Italy
[6] Osped Riuniti, Unit Med Oncol, I-60126 Ancona, Italy
[7] San Carlo Hosp, Unit Med Oncol, I-85100 Potenza, Italy
[8] Campus Biomed Univ, Med Oncol, I-00128 Rome, Italy
[9] Gen Hosp, Dept Med Oncol, I-59100 Prato, Italy
[10] Ist Ospitalieri Cremona, Med Oncol Div, I-26100 Cremona, Italy
[11] Natl Canc Inst IRCCS Giovanni Paolo II, Unit Med Oncol, I-70124 Bari, Italy
[12] Natl Canc Inst IRCCS, Med Oncol, I-20133 Milan, Italy
[13] IOV IRCCS, Med Oncol, I-35128 Padua, Italy
[14] Univ Cagliari, Univ Hosp, Unit Med Oncol, I-09124 Cagliari, Italy
[15] IRCCS Fdn G Pascale, Natl Canc Inst, Gastrointestinal Oncol, I-80131 Naples, Italy
[16] Perrino Hosp, Unit Med Oncol, I-72100 Brindisi, Italy
[17] Univ Verona, Unit Med Oncol, I-37126 Verona, Italy
[18] Careggi Univ Hosp, Unit Med Oncol, I-50134 Florence, Italy
[19] Vito Fazzi Hosp, Unit Oncol, I-73100 Lecce, Italy
[20] ULSS 8 Berica East Dist, San Bortolo Gen Hosp, Dept Oncol, I-36100 Vicenza, Italy
关键词
chemotherapy; metastatic gastric cancer; palliative gastrectomy; GASTRIC-CANCER; PALLIATIVE RESECTION; DOUBLE-BLIND; CHEMOTHERAPY; SURGERY; ADENOCARCINOMA; PHASE-3; GUIDELINES;
D O I
10.2217/fon-2017-0246
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To evaluate the impact on overall survival (OS) of gastrectomy in asymptomatic metastaticesophago-gastriccancer.Patients&methods: Five hundred and thirteen patients were included. The role of surgery and other clinico-pathological factors was evaluated by univariate and Cox regression analyses. OS was the primary end point. Results: Multivariate analysis confirmed that gastrectomy was a predictor of longer OS (p < 0.001), as well as preserved performance status and benefit from first-line chemotherapy. None of the investigated clinico-pathological variables identified preferable candidates for surgery (all p > 0.05). Conclusion: Palliative gastrectomy might play a role in asymptomatic metastatic esophago-gastric cancer patients with good performance status who received benefit from first-line chemotherapy. Future prospective trials integrating tumor biology among inclusion criteria may help defining the optimal candidates.
引用
收藏
页码:2265 / 2275
页数:11
相关论文
共 50 条
  • [31] Value of staging laparoscopy for multimodal therapy planning in Esophago-Gastric cancer
    Kaiser, Gernot M.
    Sotiropoulos, Georgios C.
    Fruehauf, Nils R.
    Stavrou, Gregor A.
    Peitgen, Klaus
    Poettgen, Christoph
    Gerken, Guido
    Paul, Andreas
    Broelsch, Christoph E.
    INTERNATIONAL SURGERY, 2007, 92 (03) : 128 - 132
  • [33] Biomarkers and novel agents in esophago-gastric cancer: are we making progress?
    Dahle-Smith, Asa
    Petty, Russell D.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (09) : 1103 - 1119
  • [34] TREATMENT OF THORACIC ESOPHAGEAL CANCER WITH CERVICAL ESOPHAGO-GASTRIC PLASTIC-SURGERY
    GIGNOUX, M
    SEGOL, P
    OLLIVIER, JM
    BRICARD, H
    LYON CHIRURGICAL, 1978, 74 (04) : 262 - 264
  • [35] ASO Author Reflections: Preventable Mortality Following Esophago-Gastric Cancer Resection
    Liu, David S. S.
    Bright, Tim
    Watson, David I.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (08) : 4962 - 4963
  • [36] Cervical esophago-gastric anastomosis using linear cutter stapler in esophageal cancer
    Patel, Parth Kanaiyalal
    Shah, Mishal
    Patni, Sanjeev
    Saini, Shashikant
    INDIAN JOURNAL OF CANCER, 2017, 54 (04) : 669 - 672
  • [37] Three methods of anastomosis in esophagojejunostomy of laparoscopic trans-hiatal extended gastrectomy for typeii,iii esophago-gastric junction cancer
    Tong, W. H.
    Wang, Q.
    Suo, J.
    Sun, D. H.
    9TH INTERNATIONAL GASTRIC CANCER CONGRESS (IGCC 2011): A GATE TO THE FUTURE OF GASTRIC CANCER TREATMENT, 2011, : 209 - 211
  • [38] ASO Author Reflections: Preventable Mortality Following Esophago-Gastric Cancer Resection
    David S. Liu
    Tim Bright
    David I. Watson
    Annals of Surgical Oncology, 2023, 30 : 4962 - 4963
  • [39] Sensitivity and specifity of impedance planimetry (EndoFLIP®) to reveal functional or structural esophago-gastric junction pathology
    Lenglinger, Johannes
    Linas, Ioannis
    Handschuh, Patricia
    Tutuian, Radu
    SWISS MEDICAL WEEKLY, 2016, 146 : 10S - 10S
  • [40] EVALUATION OF DOCETAXEL, CISPLATIN AND CAPECITABINE (DCX) AS PERIOPERATIVE CHEMOTHERAPY FOR RESECTABLE GASTRIC AND ESOPHAGO-GASTRIC CANCER
    Marcelo, Garrido
    Maria, Sanchez
    Paula, Fonseca
    Carmen, Gonzalez-Rey
    Alberto, Carmona
    Maria, Solis
    Laura, Faez
    David, Rodriguez
    Ana, Ruiz
    Madalina, Frunza
    Juan, Briones
    Claudia, Giraldo
    Bruno, Nervi
    Alejandro, Gomez-Pinillos
    Jose Maria, Vieitez de Prado
    ANNALS OF ONCOLOGY, 2014, 25 : 39 - 39